Pontifical Catholic University of Rio Grande do Sul   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Porto Alegre Brazil (1900)

Organization Overview

First Clinical Trial
2005
NCT00959907
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Brazilan Center for Studies in Dermatology | Brazilian Center for Dermatologic Studies | Brazilian Center for Studies in Dermatology | BRAZILIAN CENTER FOR STUDIES IN DERMATOLOGY | Brazilian Center for Studies in Dermatology (CBED) | Department of Pediatrics School of Medicine, PUCRS, Brazil | Pontificia Universidade Católica do Rio Grande do Sul | Pontifícia Universidade Católica do Rio Grande do Sul | Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 2)

Cocaine-Related Disorders (Phase 2)

Dental Caries (Phase 3)

Depression (Phase 4)

Leishmaniasis (Phase 2)

Leishmaniasis, Cutaneous (Phase 2)

Striae Distensae (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 19